Patents by Inventor Louis Moreau

Louis Moreau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Contactless payment method and device, using a re-usable card
    Patent number: 6874685
    Abstract: In a transport system using contactless microcircuit cards, users are obliged to hand in a card when the credit shown on it has been used up. The value of the cards is recharged and they are then sold again. Recovering and recharging the cards reduces the ticketing cost per journey.
    Type: Grant
    Filed: October 4, 1999
    Date of Patent: April 5, 2005
    Assignee: Alcatel
    Inventors: Jean-Louis Moreau, Marcel Simonin
  • Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
    Patent number: 6825334
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Grant
    Filed: March 1, 2001
    Date of Patent: November 30, 2004
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Golberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
    Publication number: 20040202661
    Abstract: The present invention relates to new peptides of IL-2, derivatives thereof, and their use as therapeutic agents.
    Type: Application
    Filed: December 5, 2003
    Publication date: October 14, 2004
    Applicant: INSTITUT PASTEUR
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Golberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • DNA encoding peptides of IL-2
    Patent number: 6596853
    Abstract: The invention relates to the use as therapeutic agents of IL-2 peptides and derivatives having biological activity and anti-IL-2 antibodies which mimic or modulate the biological activities of IL-2. The invention also relates to DNA sequences encoding the IL-2 peptides, and to methods of using the IL-2 peptides and derivatives and anti-IL-2 antibodies to modulate or mimic or antagonize the biological activities of IL-2 in vivo and to assay for the presence and activity of the IL-2 receptor.
    Type: Grant
    Filed: September 12, 2000
    Date of Patent: July 22, 2003
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Jean-Claude Mazie
  • Secure computer system
    Publication number: 20030023863
    Abstract: The secure computer system comprises at least one computer having a processor operating under the control of a program on input data that can be associated with a code and delivering output data for output members. A security peripheral that is external but connected to the processor is provided to receive at least the input data codes, the operands, and the nature of the operation of each elementary operation performed by the processor, a code being calculated on each elementary operation performed by the processor in order to verify proper performance of all or part of the executed program. The system is applicable to processes for automatically running rail track systems.
    Type: Application
    Filed: June 8, 2001
    Publication date: January 30, 2003
    Inventors: Said El Fassi, Louis Moreau
  • Peptides of IL-2 and derivatives thereof and their use as therapeutic agents
    Publication number: 20020044935
    Abstract: The present invention relates to new peptides of IL-2, and derivatives thereof and their use as therapeutic agents.
    Type: Application
    Filed: February 6, 2001
    Publication date: April 18, 2002
    Applicant: INSTITUT PASTEUR
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose, Pedro Alzari, Jean-Claude Mazie
  • Biological applications of new peptides of IL-2 and derivatives and use as therapeutic agents
    Patent number: 6168785
    Abstract: The invention relates to the use as therapeutic agents of IL-2 peptides and derivatives having biological activity and anti-IL-2 antibodies which mimic or modulate the biological activities of IL-2. The invention also relates to DNA sequences encoding the IL-2 peptides, and to methods of using the IL-2 peptides and derivatives and anti-IL-2 antibodies to modulate or mimic or antagonize the biological activities of IL-2 in vivo and to assay for the presence and activity of the IL-2 receptor.
    Type: Grant
    Filed: July 16, 1998
    Date of Patent: January 2, 2001
    Assignee: Institut Pasteur
    Inventors: Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Jean-Claude Mazie